Acadia Pharmaceuticals | SCHULD



Debt Veränderung Datum
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Corcept Therapeutics USD 6.6M 6.6M 2025-06
Cytokinetics USD 658.13M 1.01M 2025-03
Eisai JPY 187.52B 31.58B 2025-03
Eli Lilly USD 39.9B 1.39B 2025-06
Incyte USD 42.41M 5.29M 2025-06
J&J USD 52.25B 15.62B 2025-03
Moderna USD 741M 4M 2025-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.93B 1.18B 2025-06
Prothena USD 0 0 2024-12
PTC Therapeutics USD 286.01M 2.12B 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Acadia Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.